Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective

Klaus Kaier (), Silvia Hils (), Stefan Fetzer (), Philip Hehn (), Anja Schmid (), Dieter Hauschke (), Lioudmila Bogatyreva (), Bernd Jänigen () and Przemyslaw Pisarski ()
Additional contact information
Klaus Kaier: Faculty of Medicine and Medical Center – University of Freiburg
Silvia Hils: University of Freiburg
Stefan Fetzer: Aalen University
Philip Hehn: Faculty of Medicine and Medical Center – University of Freiburg
Anja Schmid: University of Freiburg
Dieter Hauschke: Faculty of Medicine and Medical Center – University of Freiburg
Lioudmila Bogatyreva: Faculty of Medicine and Medical Center – University of Freiburg
Bernd Jänigen: University of Freiburg
Przemyslaw Pisarski: University of Freiburg

Health Economics Review, 2017, vol. 7, issue 1, 1-8

Abstract: Abstract ᅟ We analyze one-year costs and savings of a telemedically supported case management program after kidney transplantation from the perspective of the German Healthcare System. Recipients of living donor kidney transplantation (N = 46) were randomly allocated to either (1) standard aftercare or (2) standard aftercare plus additional telemedically supported case management. A range of cost figures of each patient’s medical service utilization were calculated at month 3, 6 and 12 and analyzed using two-part regression models. In comparison to standard aftercare, patients receiving telemedically supported case management are associated with substantial lower costs related to unscheduled hospitalizations (mean difference: €3,417.46 per patient for the entire one-year period, p = 0.003). Taking all cost figures into account, patients receiving standard aftercare are associated, on average, with one-year medical service utilization costs of €10,449.28, while patients receiving telemedically supported case management are associated with €5,504.21 of costs (mean difference: € 4,945.07 per patient, p

Keywords: Telemedicine; Cost-of-illness; Cost-benefit (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1186/s13561-016-0141-3 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:hecrev:v:7:y:2017:i:1:d:10.1186_s13561-016-0141-3

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/13561

DOI: 10.1186/s13561-016-0141-3

Access Statistics for this article

Health Economics Review is currently edited by J. Matthias Graf von der Schulenburg

More articles in Health Economics Review from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().